Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.
about
Diagnosing COPD: advances in training and practice - a systematic reviewA breath of fresh air: images of respiratory illness in novels, poems, films, music, and paintings.Integrating patients into meaningful real-world research.Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials.Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised studyRisk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort studyPreventing COPD exacerbations: new options for a crucial and growing problemAclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)Features of a Mobile Support App for Patients With Chronic Obstructive Pulmonary Disease: Literature Review and Current Applications.Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.Effect of Indacaterol on Cough and Phlegm in Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Five Randomized Controlled Trials.Understanding and measuring symptoms and health status in asthma COPD overlap: content validity of the EXACT and SGRQ
P2860
Q26751313-B3019A3C-47F4-4776-9BEC-8FBC02AE9183Q30372619-9535320A-94A8-4F82-94B1-183947AF45D8Q33440620-428B13C5-3A69-48DC-B620-CDED9F9AEBC5Q34374637-6C2BF248-2D8E-4FB5-BFCE-6337DBE72A48Q34423324-06B74B01-6780-44DD-8E77-A4DB47FD8002Q34753755-21D62E26-3605-488A-9A4D-6D7EC472544AQ34767932-4B53CBBC-636E-48A4-8459-ABF7E8C1A563Q35149776-B2EDBDA1-9A9D-4096-83AA-91EB8AD9291BQ35937943-236276D0-B73E-4981-AB23-48B40A993B93Q37683389-5B374C0E-BA85-4334-8F01-DA33539D429AQ38690517-493EA730-EA97-4828-BC70-EB3736EC610CQ41665001-7C0595FA-6776-4898-8493-C5B7E53AD423Q41897903-6E7E8276-32BE-48AB-843A-DF64EE86F28FQ56764323-9FB1E6A6-50C1-4C40-8824-24545A525BA2
P2860
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.
@en
type
label
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.
@en
prefLabel
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.
@en
P2860
P1476
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.
@en
P2093
Lindsey T Murray
Nancy K Leidy
P2860
P304
P356
10.3109/15412555.2013.795423
P407
P577
2013-06-01T00:00:00Z